RECHEM
Welcome to our website!|Hot Line: 86-21-31433387|E-mail: sales@rechemscience.com
Products Category
Contact Us
| Tel: | +86-21-31433387 |
| +86-15618786686 | |
| Email: | sales@rechemscience.com |
| info@rechemscience.com | |
| QQ: | 1369748377 |
| Skype: | sales@rechemscience.com |
| Cat.No. | Product name | Product Description |
| R00314 | Defactinib | Defactinib (VS-6063; PF-04554878) is a novel FAK inhibitor with potential antian |
| R00315 | Defactinib hydrochloride;VS-6063 hydrochloride; PF 04554878 hydrochloride | Defactinib hydrochloride (VS-6063 hydrochloride; PF 04554878 hydrochloride) is a |
| R00318 | Donepezil;E2020 free base | Donepezil (E2020 free base) is a specific and potent AChE inhibitor with IC50s o |
| R00320 | olodaterol hydrochloride | Olodaterol hydrochloride is the hydrochloride salt form of Olodaterol, which is |
| R00321 | RET-IN-1 | RET-IN-1 is a RET kinase inhibitor extracted from patent WO2018071447A |
| R2030458 | Ulixertinib hydrochloride (BVD-523 hydrochloride; VRT752271 hydrochloride) | Ulixertinib hydrochloride (BVD-523 hydrochloride) is a potent, orally active, hi |
| R2032111 | ALK2-IN-1;BLU782 | ALK2-IN-1 is a activin receptor-like kinase-2 (ALK2) inhibitor extracted from pa |
| R2032112 | SRT2104;GSK2245840 | SRT 2104 is a first-in-class, highly selective and brain-permeable activator of |
| R2032113 | NG25 | NG25 is a potent dual TAK1 and MAP4K2 inhibitor, with IC50s of 149 nM and 21.7 n |
| R2032114 | GDC0623;GDC-0623;RG 7421;MEK inhibitor 1 | GDC-0623 (RG 7421) is a potent, ATP-uncompetitive inhibitor of MEK1 (Ki=0.13 nM, |
| R2032115 | AZD2858 | AZD2858 is a potent, orally active GSK-3 inhibitor, with IC50s of 0.9 and 5 nM f |
| R2032116 | AZD3463;AZD-3463;ALK/IGF1R inhibitor | AZD-3463 is an ALK/IGF1R inhibitor which overcomes multiple mechanisms of acquir |
| R2032117 | Ko143 | Ko 143 is a potent and selective ATP-binding cassette sub-family G member 2 (ABC |
| R2032118 | ABT737;ABT-737 | ABT-737 is a selective and BH3 mimetic Bcl-2, Bcl-xL and Bcl-w inhibitor with EC |
| R2032119 | A-803467;A803467 | A 803467 is a selective Nav1.8 sodium channel blocker with an IC50 of 8 nM; over |
| R2032120 | AC55541 | AC-55541 is a highly selective protease-activated receptor 2 (PAR2) agonist (pEC |
| R2032121 | AGI5198;AGI-5198;IDH-C35 | AGI-5198 is a potent and selective mutant IDH1R132H inhibitor with an IC50 of 0. |
| R2032122 | Onalespib;AT13387 | Onalespib (AT13387) is a potent inhibitor of Hsp90, with a Kd of 0.71 nM. |
| R2032123 | Luminespib;NVP-AUY922;VER-52296 | Luminespib (NVP-AUY922) is a potent HSP90 inhibitor with IC50s of 7.8 and 21 nM |
| R2032124 | Cediranib(AZD2171) | Cediranib (AZD2171) is a highly potent, orally available VEGFR tyrosine kinase i |
| R2032125 | Temsirolimus;CCI-779 | Temsirolimus is an inhibitor of mTOR with an IC50 of 1.76 μM. |
| R2032126 | Retigabine | Retigabine(free base) is a novel anticonvulsant with activity in a broad range o |
| R2032127 | Batimastat;BB94 | Batimastat is a potent broad spectrum MMP inhibitor with IC50 of 3, 4, 4, 6, and |
| R2032128 | Marimastat;BB2516;TA2516 | Marimastat (BB2516) is a broad spectrum and orally bioavailable inhibitor of MMP |
| R2032129 | Epoxomicin | Epoxomicin is a cell-permeable and irreversible proteasome inhibitor, primarily |
